SEC Filing Analysis: Charles River Laboratories International, Inc. (CRL)

Executive Summary

• Trading Significance: Medium
• Key Takeaway: Nomura Holdings, a major institutional investor, has filed a Schedule 13G/A indicating its beneficial ownership in Charles River Laboratories has fallen to 1.6%, below the 5% reporting threshold.
• Market Impact: Neutral. This signals a significant position reduction by a large institution, which could be due to various portfolio management reasons and not necessarily a negative outlook on the company itself.

Company Information

Field	Value
Company	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Ticker Symbol	CRL (Note: Not explicitly in filing, sourced externally for context)
CIK	0001100682
Industry	Services-Commercial Physical & Biological Research

Reporting Entity Information

Field	Value
Name	NOMURA HOLDINGS INC
CIK	0001163653
Title/Position	Holding Company
Relationship	Passive Investor

Position Details

Field	Value
Form Type	SCHEDULE 13G/A (Amendment)
Event Date	2025-09-30
Security Type	Common Stock, $0.01 par value per share
Shares Owned After	807,923
Ownership Type	Indirect

Financial Impact Assessment

This filing reports a change in ownership status rather than a single transaction. The key event is the filer's ownership dropping below the 5% mandatory reporting level.

Position Materiality

Metric	Value
Shares Held	807,923
Shares Outstanding (per filing)	49,215,000
Post-Filing Ownership	1.6% of outstanding shares
Materiality Assessment	Medium. The primary significance comes from a major institutional holder ceasing to be a 5%+ owner, not the size of the remaining stake.

Impact Evaluation

• Ownership Concentration: Nomura's exit from the 5%+ owner category reduces the concentration of large institutional holders. The remaining 1.6% stake is still substantial but no longer requires public disclosure for minor changes.
• Transaction Significance: The filing is an amendment certifying that Nomura's ownership has fallen below 5%. This is a noteworthy event for investors who track institutional money flow, as it represents a significant divestment over an unspecified period.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: A reduction in stake by a large passive investor is common for portfolio rebalancing, profit-taking, or changes in investment strategy. Without evidence of a specific negative catalyst, the market impact is likely neutral as the information is absorbed.

Volume & Sentiment

• Expected Volume Impact: Minimal direct impact, as the sales that led to this status change have already occurred. It may influence future sentiment if other institutions follow suit.
• Sentiment Indicator: Neutral. The filing confirms a past action (selling) rather than a future intention. It removes an overhang of a large seller but also removes a large holder.

Investment Insights

Risk Factors

• A major institutional holder has significantly reduced its position. While the reasons are unknown, it removes a source of long-term institutional support.

Key Takeaways

1. Change in Holder Status: Nomura Holdings is no longer a reportable 5%+ beneficial owner of Charles River Labs.
2. Passive Investment Reduction: The filing confirms the shares were held as a passive investment, meaning the reduction is not related to activism or an attempt to influence company control.
3. Remaining Stake: Nomura still holds a 1.6% stake (807,923 shares), indicating it has not fully exited its position.

Additional Context

Transaction Notes

• This Schedule 13G/A is an amendment to a previous filing, triggered by the reporting person's beneficial ownership falling below 5% of the company's outstanding common stock.
• The ownership is held indirectly through wholly-owned subsidiaries: Nomura Global Financial Products, Inc., Nomura Securities International, Inc., and Nomura International PLC.